Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer.

Saved in:
Bibliographic Details
Title: Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer.
Authors: Chang WH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Vaughan AJ; Department of Pathology, NYU Langone Health, New York, New York.; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York., Stamey AG; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Mancini M; Department of Pathology, NYU Langone Health, New York, New York.; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.; Department of Biochemistry, Federal University of São Paulo, São Paulo, Brazil., Hayashi M; Department of Pathology, NYU Langone Health, New York, New York.; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York., Yang R; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Robb R; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Andrussier D; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York., Klomp JA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Waters AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Schaefer A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bryant KL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Cox AD; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Simabuco FM; Department of Biochemistry, Federal University of São Paulo, São Paulo, Brazil., Wong KK; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York., Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Stalnecker CA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Papagiannakopoulos T; Department of Pathology, NYU Langone Health, New York, New York.; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York., Der CJ; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Apr 21. Date of Electronic Publication: 2026 Apr 21.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.04.18.719329